Statistics of Inflammatory Breast Cancer

Executive Summary

Around 1% to 5% of all breast cancer cases comprise Inflammatory breast cancer statistics. Black women appear to have a greater risk of inflammatory breast cancer than white women. Also, few men are diagnosed with inflammatory breast cancer at an older age. 1 out of 3 people with inflammatory breast cancer has already shown metastasis during their diagnosis. The 5-year survival rate for people having inflammatory breast cancer is 41%. Cancer, when it grows to the regional lymph nodes, has shown a 5-year survival rate to be at 56%. If cancer has spread to a distant part of the body, the 5-year survival rate is 19%.

Statistics of Inflammatory Breast Cancer

Based on Statistics of Inflammatory breast cancer reports for 1% to 5% of all breast cancers ​1​. This disease usually occurs in women younger than 40. Black women appear to have a greater risk of inflammatory breast cancer than white women. Inflammatory breast cancer also occurs in men. Men are typically older when diagnosed with inflammatory breast cancer compared with women ​2​.


Inflammatory breast cancer is usually at a locally advanced stage when diagnosed as the breast cancer cells have grown into the skin. For around 1 out of 3 people with inflammatory breast cancer, cancer has already metastasized when first diagnosed ​3​.


The 5-year survival rate reveals what per cent of people live at least five years after the cancer is found. The 5-year survival rate for people having inflammatory breast cancer is 41% ​4​.


However, survival rates can vary widely and depend on several factors, including the type and stage of the tumor. If cancer has grown to the regional lymph nodes, the 5-year survival rate is 56%. If cancer has spread to a distant part of the body, the 5-year survival rate is 19%.


It is noteworthy that statistics on the survival rates for people with inflammatory breast cancer are an estimate.

References

  1. 1.
    Anderson W, Schairer C, Chen B, Hance K, Levine P. Epidemiology of inflammatory breast cancer (IBC). Breast Dis. 2005;22:9-23. doi:10.3233/bd-2006-22103
  2. 2.
    Yamauchi H, Woodward WA, Valero V, et al. Inflammatory Breast Cancer: What We Know and What We Need to Learn. The Oncologist. Published online May 14, 2012:891-899. doi:10.1634/theoncologist.2012-0039
  3. 3.
    Dabi Y, Darrigues L, Pons K, et al. Incidence of inflammatory breast cancer in patients with clinical inflammatory breast symptoms. Ahmad A, ed. PLoS ONE. Published online December 20, 2017:e0189385. doi:10.1371/journal.pone.0189385
  4. 4.
    Schlichting JA, Soliman AS, Schairer C, Schottenfeld D, Merajver SD. Inflammatory and non-inflammatory breast cancer survival by socioeconomic position in the Surveillance, Epidemiology, and End Results database, 1990–2008. Breast Cancer Res Treat. Published online June 26, 2012:1257-1268. doi:10.1007/s10549-012-2133-2